The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for ...
Teos Therapeutics has potential lung cancer treatment despite issues and strong financial position. Read here to know why we ...
The FDA granted breakthrough therapy designation to sacituzumab govitecan for patients with ES-SCLC progressing on platinum ...
Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...
The FDA issues a complete response letter to JNJ's BLA seeking approval for the subcutaneous formulation of Rybrevant in EGFR ...
China National Medical Products Administration (NMPA) has approved MSD’s KEYTRUDA for treating certain non-small cell lung cancer (NSCLC).
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...
Jazz Pharmaceuticals announced that the FDA has approved ZIIHERA® (zanidatamab-hrii) on an accelerated basis for the treatment ...
Nicole Cianciotti had driven only about 4½ miles from UPMC Children’s East when she got the call that her son Braeden’s left ...
The spirometer (built-in 1846 by Hutchinson) measures ventilatory function (dynamic lung volumes and maximal flow rates). Miller 1996 [1]) shows a normal spirogram showing the measurements of forced ...